APA

Chovanec J., Selingerova I., Greplova K., Antonsen S. L., Nalezinska M., Høgdall C., Høgdall E., Søgaard-Andersen E., Jochumsen K. M., Fabian P., Valik D. & Zdrazilova-Dubska L. (2017). Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer. : Oncotarget.

Chicago

Chovanec Josef, Selingerova Iveta, Greplova Kristina, Antonsen Sofie Leisby, Nalezinska Monika, Høgdall Claus, Høgdall Estrid, Søgaard-Andersen Erik, Jochumsen Kirsten M, Fabian Pavel, Valik Dalibor and Zdrazilova-Dubska Lenka. 2017. Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer. : Oncotarget.

Harvard

Chovanec J., Selingerova I., Greplova K., Antonsen S. L., Nalezinska M., Høgdall C., Høgdall E., Søgaard-Andersen E., Jochumsen K. M., Fabian P., Valik D. and Zdrazilova-Dubska L. (2017). Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer. : Oncotarget.

MLA

Chovanec Josef, Selingerova Iveta, Greplova Kristina, Antonsen Sofie Leisby, Nalezinska Monika, Høgdall Claus, Høgdall Estrid, Søgaard-Andersen Erik, Jochumsen Kirsten M, Fabian Pavel, Valik Dalibor and Zdrazilova-Dubska Lenka. Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer. : Oncotarget. 2017.